感染症科

Medicine & Life Sciences

1. 16S Ribosomal RNA 6%
2. 5,6-dihydroxy-2-methylaminotetralin 11%
3. aerobactin 7%
4. Anti-Bacterial Agents 19%
5. Antibodies 10%
6. Antigens 11%
7. Aortic Aneurysm 20%
8. Bacteremia 22%
9. Blood Culture 12%
10. Bronchopneumonia 12%
11. carbapenemase 8%
12. Catheter-Related Infections 23%
13. Catheters 14%
14. Ceftriaxone 9%
15. Chromosomes 19%
16. Clinical Trials 11%
17. Cohort Studies 13%
18. Coinfection 20%
19. Community Health Services 22%
20. Confidence Intervals 22%
21. Coronavirus 91%
22. Coronavirus Infections 17%
23. Critical Care 15%
24. Delayed Diagnosis 19%
25. Drug Resistance 6%
26. Embolism 18%
27. Emergency Medical Services 19%
28. Endocarditis 18%
29. Enterobacter cloacae 9%
30. Enterobacteriaceae 6%
31. Epidemics 11%
32. Epidemiology 7%
33. Escherichia coli 40%
34. favipiravir 32%
35. Fluoroquinolones 23%
36. Foot-and-Mouth Disease 26%
37. Foscarnet 25%
38. Fosfomycin 100%
39. garenoxacin 12%
40. Genes 18%
41. Genome 19%
42. Gram-Negative Bacteria 21%
43. GS-5734 6%
44. Healthcare-Associated Pneumonia 23%
45. Helicobacter 25%
46. Hospitalization 6%
47. IgG Receptors 8%
48. Infected Aneurysm 25%
49. Infections 39%
50. Integrons 8%
51. Japan 34%
52. Klebsiella pneumoniae 26%
53. Kluyvera 11%
54. Livestock 11%
55. Lung 14%
56. Macrolides 6%
57. Meningitis 18%
58. Meropenem 14%
59. Mesylates 11%
60. Methicillin-Resistant Staphylococcus aureus 20%
61. Metronidazole 20%
62. Mortality 10%
63. Mucormycosis 24%
64. Multilocus Sequence Typing 8%
65. Necrotizing Pneumonia 7%
66. Neoplasms 11%
67. Observational Studies 17%
68. Odds Ratio 24%
69. Pathology 11%
70. Pediatrics 11%
71. Pharmaceutical Preparations 16%
72. Plasmids 20%
73. Pneumococcal Infections 11%
74. Pneumocystis carinii 23%
75. Pneumocystis Infections 27%
76. Pneumocystis Pneumonia 22%
77. Pneumonia 46%
78. Polymerase Chain Reaction 29%
79. Proteins 11%
80. Pseudomonas aeruginosa 7%
81. Pulmonary Tuberculosis 18%
82. Respiratory Insufficiency 8%
83. Reverse Transcription 25%
84. rRNA Genes 6%
85. SARS Virus 80%
86. Seroepidemiologic Studies 6%
87. Serologic Tests 9%
88. Severe Acute Respiratory Syndrome 81%
89. Stents 10%
90. Streptococcus pneumoniae 18%
91. Systematic Reviews 13%
92. Therapeutics 10%
93. Transplants 7%
94. Tuberculosis 8%
95. Viral Load 7%
96. Virulence Factors 9%
97. Virus Shedding 24%
98. Viruses 10%
99. Whole Genome Sequencing 7%
100. Young Adult 14%